TARA NASDAQ
Protara Therapeutics, Inc.
1W: -6.2%
1M: -8.1%
3M: -27.3%
YTD: -7.6%
1Y: +42.8%
3Y: +42.4%
5Y: -44.8%
$4.92
-0.05 (-1.01%)
Weekly Expected Move ±5.8%
$5
$5
$5
$5
$6
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q1 2026134
Institutions Holding
+21 vs prior
97.4%
Ownership
-14.30%
30
New
42
Increased
54
Reduced
35
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-04-08 | Zummo Jacqueline | officer: chief r&d officer | S-Sale | 1,134 | $5.40 | $6K | Filing |
| 2026-01-26 | Shefferman Jesse | officer: ceo and president | F-Tax Withholding | 8,732 | $6.67 | $58K | Filing |
| 2026-01-26 | Zummo Jacqueline | officer: chf scientific operations off | F-Tax Withholding | 3,724 | $6.67 | $25K | Filing |
| 2026-01-26 | Fry Hannah | officer: vp, controller | F-Tax Withholding | 1,457 | $6.67 | $10K | Filing |
| 2026-01-26 | Fabbio Patrick | officer: chief financial officer | F-Tax Withholding | 3,261 | $6.67 | $22K | Filing |
| 2026-01-20 | Fabbio Patrick | officer: chief financial officer | F-Tax Withholding | 3,063 | $5.60 | $17K | Filing |
| 2026-01-20 | Fry Hannah | officer: vp, controller | F-Tax Withholding | 2,132 | $5.60 | $12K | Filing |
| 2026-01-20 | Zummo Jacqueline | officer: chf scientific operations off | F-Tax Withholding | 6,578 | $5.60 | $37K | Filing |
| 2026-01-20 | Shefferman Jesse | officer: ceo and president | F-Tax Withholding | 16,322 | $5.60 | $91K | Filing |
| 2026-01-16 | CONKLING WILLIAM | officer: chief commercial officer | A-Grant/Award | 26,000 | $— | $0 | Filing |
| 2026-01-16 | Fabbio Patrick | officer: chief financial officer | A-Grant/Award | 28,000 | $— | $0 | Filing |
| 2026-01-16 | Fry Hannah | officer: vp, controller | A-Grant/Award | 9,500 | $— | $0 | Filing |
| 2026-01-16 | Nicacio Leonardo Viana | officer: chief medical officer | A-Grant/Award | 26,000 | $— | $0 | Filing |
| 2026-01-16 | Zummo Jacqueline | officer: chf scientific operations off | A-Grant/Award | 30,000 | $— | $0 | Filing |
| 2026-01-16 | Shefferman Jesse | officer: ceo and president | A-Grant/Award | 87,000 | $— | $0 | Filing |
| 2025-06-27 | Shefferman Jesse | officer: ceo and president | G-Gift | 10,200 | $— | $0 | Filing |
| 2025-06-27 | Shefferman Jesse | officer: ceo and president | G-Gift | 3,367 | $— | $0 | Filing |
| 2025-06-26 | Shefferman Jesse | officer: ceo and president | G-Gift | 3,400 | $— | $0 | Filing |
| 2025-06-26 | Shefferman Jesse | officer: ceo and president | G-Gift | 1,700 | $— | $0 | Filing |
| 2025-06-24 | Shefferman Jesse | officer: ceo and president | G-Gift | 300,000 | $— | $0 | Filing |
| 2025-06-02 | CONKLING WILLIAM | officer: chief commercial officer | A-Grant/Award | 50,000 | $— | $0 | Filing |
| 2025-05-14 | Levy Richard S | director | P-Purchase | 20,000 | $3.19 | $64K | Filing |
| 2025-05-14 | Levy Richard S | director | P-Purchase | 20,000 | $3.19 | $64K | Filing |
| 2025-04-15 | Nicacio Leonardo Viana | officer: chief medical officer | A-Grant/Award | 50,000 | $— | $0 | Filing |
| 2025-03-26 | Zummo Jacqueline | officer: chf scientific operations off | S-Sale | 21,224 | $4.53 | $96K | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 5,207,011 | $27M | +65,395 | 2026-03-31 | Filing |
| BlackRock, Inc. | 3,394,968 | $18M | +986,100 | 2026-03-31 | Filing |
| Velan Capital Investment Management LP | 2,834,652 | $15M | — | 2026-03-31 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 2,119,018 | $11M | +2,119,018 | 2026-03-31 | Filing |
| Sio Capital Management, LLC | 1,969,839 | $10M | +254,445 | 2026-03-31 | Filing |
| ACORN CAPITAL ADVISORS, LLC | 1,752,115 | $9M | — | 2026-03-31 | Filing |
| Integral Health Asset Management, LLC | 1,750,000 | $9M | -500,000 | 2026-03-31 | Filing |
| AIGH Capital Management LLC | 1,622,733 | $8M | +1,622,733 | 2026-03-31 | Filing |
| UBS Group AG | 1,402,413 | $7M | +186,876 | 2026-03-31 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 1,177,200 | $6M | +360,004 | 2026-03-31 | Filing |
| Point72 Asset Management, L.P. | 1,152,714 | $6M | +1,124,607 | 2026-03-31 | Filing |
| Patient Square Capital LP | 1,030,846 | $5M | +1,030,846 | 2026-03-31 | Filing |
| STATE STREET CORP | 1,005,142 | $5M | +434,264 | 2026-03-31 | Filing |
| ADAR1 Capital Management, LLC | 940,512 | $5M | -196,287 | 2026-03-31 | Filing |
| BANK OF AMERICA CORP /DE | 925,918 | $5M | +430,014 | 2026-03-31 | Filing |
| J. Goldman & Co LP | 856,247 | $4M | +856,247 | 2026-03-31 | Filing |
| Catalio Capital Management, LP | 580,024 | $3M | -866,230 | 2026-03-31 | Filing |
| Assenagon Asset Management S.A. | 567,621 | $3M | +259,287 | 2026-03-31 | Filing |
| DIMENSIONAL FUND ADVISORS LP | 531,267 | $3M | +304,110 | 2026-03-31 | Filing |
| Walleye Capital LLC | 443,401 | $2M | +297,525 | 2026-03-31 | Filing |